Instil Bio (TIL) Cash & Equivalents (2020 - 2026)
Instil Bio (TIL) recorded Cash & Equivalents of $5.54 million in Q2 2026, down 27.9% from $7.69 million a year earlier but up 10.3% from the prior quarter.
Powered by 
Analysis
Instil Bio (TIL) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Instil Bio reported Cash & Equivalents of $6.64 million, down 24.6% from FY2024.
- Annual Cash & Equivalents has declined for three straight years, with a five-year compound annual growth rate of -51.3% (FY2020 to FY2025).
- Across earlier years, Cash & Equivalents came in at $8.81 million in FY2024 (-4.2%), $9.2 million in FY2023 (-79.0%), $43.72 million in FY2022 (+16.3%) and $37.59 million in FY2021 (-84.4%).
- Quarterly Cash & Equivalents has ranged from $5.02 million in Q1 2026 to $61.47 million in Q1 2022 over the past five years.
- On a year-over-year basis, Cash & Equivalents has declined for four consecutive quarters, with growth averaging 3.7% over the last eight quarters.
- Peak year-over-year performance for Cash & Equivalents in the last five years was growth of 180.2% in Q1 2025, against a decline of 92.5% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $5.02 million (Q1 2026), $6.64 million (Q4 2025) and $5.8 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,138.00 Bn | 1,106.58 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 634.40 Bn | 554.26 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 506.36 Bn | 479.47 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 358.30 Bn | 312.68 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 293.12 Bn | 257.11 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 265.36 Bn | 239.05 Bn | 12.86 Bn | 4.90 Bn |
| 7 | Amgen | 238.40 Bn | 193.80 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 195.15 Bn | 169.35 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 170.83 Bn | 117.47 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Instil Bio | 39.47 Mn | 16.47 Mn | - | 5.54 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.54 Mn |
| Mar 31, 2026 | 5.02 Mn |
| Dec 31, 2025 | 6.64 Mn |
| Sep 30, 2025 | 5.80 Mn |
| Jun 30, 2025 | 7.69 Mn |
| Mar 31, 2025 | 15.37 Mn |
| Dec 31, 2024 | 8.81 Mn |
| Sep 30, 2024 | 6.66 Mn |
| Jun 30, 2024 | 6.78 Mn |
| Mar 31, 2024 | 5.48 Mn |
| Dec 31, 2023 | 9.20 Mn |
| Sep 30, 2023 | 9.13 Mn |
| Jun 30, 2023 | 21.76 Mn |
| Mar 31, 2023 | 27.35 Mn |
| Dec 31, 2022 | 43.72 Mn |
| Sep 30, 2022 | 41.12 Mn |
| Jun 30, 2022 | 42.46 Mn |
| Mar 31, 2022 | 61.47 Mn |
| Dec 31, 2021 | 37.59 Mn |
| Sep 30, 2021 | 20.40 Mn |
API Access
Instil Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TIL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "TIL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=TIL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();